For more information on the GID BIO Osteoarthritis clinical trial click here


Success is best when it's shared.

Meet our team

A team is more than a collection of people.

Roy J. Bostock


William Cimino, PhD


Dale Tomrdle


Frank DiLazzaro


Adam Katz, MD


Morgan St. John


Ramón Llull, MD, PhD


G. Patrick Maxwell, MD


Claire Tillyer, PhD


John Marous


J. William Futrell, MD


Nicholas Pachuda


Stephen C. Smith


Sandeep Samudre, MPH, PhD


Join us

Interested in joining our team?

GID BIO doesn’t have any roles available at the moment, but if you would like to be considered for any future openings please feel free to contact us.


Chair of the Board of Directors

Roy is an investor and businessman who has helped lead numerous global enterprises spanning the fields of advertising, aerospace, manufacturing, technology and finance. Bostock had a long and successful career in the advertising arena, which included engineering a merger to form the seventh largest global agency group, later acquired by Publicis Groupe in Paris. Bostock later was named Chairman of Northwest Airlines following its emergence from bankruptcy and helped architect the merger of Northwest and Delta Airlines, becoming Vice Chairman of Delta. Bostock also served as Chairman of Yahoo! Inc. and as a director of Morgan Stanley. Today, he is Chairman of his investment firm, Sealedge Investments, LLC. He graduated Phi Beta Kappa from Duke University, which he attended on a football scholarship and played both football and baseball while majoring in English literature. He earned an MBA from Harvard University.


CEO and Board of Directors

William is an experienced medical device executive specializing in medical design and business development. Cimino has over 25 years of professional experience in all aspects of medical device business, including device design and technology development, clinical studies and assessment, regulatory affairs, strategic market development, distribution, business management and growth, and funding. He has been directly responsible for the design and market introduction of over 50 medical products and has formed and run successful medical device startup companies. Dr. Cimino has been issued over 30 US patents and holds and PhD in Bioengineering, an MS in Mechanical Engineering, and a BS in Aerospace Engineering


VP Finance & Operations

Dale has 30 years of business leadership experience Dale has held executive and founding positions with venture- and angel-backed startups and has led operations, finance, IT, business development, and sales organizations at startup and large public companies. Most recently, Dale was a founding partner at NorthStone Group, LLC, where he worked with executive clients ranging from international Fortune 200 companies to venture-backed startups in the healthcare, medical device, financial service, and high-tech sectors. He has served as an interim executive for several clients. Dale has an MS from Washington State University.


VP Global Business Development

Frank has worked in the healthcare industry for the past 30 years. During that time, he has held numerous senior executive positions focusing on sales and marketing, product development, operations, and general management. Frank has a strong global background and has built sales organizations in most of the key healthcare markets. Frank was the Global President of Sales for Systagenix Wound Management, where he reorganized the global sales structure while launching a number of key new products. Prior to Systagenix, Frank built the international business for Kinetic Concepts (KCI) and was responsible for the commercialization of the VAC technology (NWPT) which has grown to become a brand worth more than one billion dollars.


Board of Directors, Founder

Dr. Katz is Professor of Plastic Surgery and Director of the Research Laboratory in the Department of Plastic and Reconstructive Surgery, Wake Forest School of Medicine. He is internationally recognized for his contributions, innovations, and expertise in the science and translation of adipose-derived cell therapies and fat grafting, including the development of device platforms that enable such. In addition to his scientific and entrepreneurial endeavours, he maintains a clinical practice that comprises both reconstructive and aesthetic surgery. He mentors and instructs students and residents at all levels in both the laboratory and clinical setting.


Board of Directors

Morgan is the Managing Partner of Wyvern Capital and has been active in merchant banking and investment banking since 1978. He has originated, analyzed, structured, negotiated and syndicated approximately $40 billion of corporate transactions in the US, Europe, Asia, and Latin America. Mr. St. John has successfully assisted and collaborated with numerous investment groups including Manhattan Pacific Partners, Actian Capital, Boyer Capital, Washington Partners Wilson Partners, and Morpheus Capital. Prior to joining Wyvern Capital, Mr. St. John was a Partner and Managing Director at Banker Trust Company, where he built the Los Angeles Finance group and New York Syndication group to become industry leaders in highly structured acquisition financing. Mr. St. John has both his bachelor’s and master’s degrees from Harvard University.



Ramon obtained his MD at University of Navarra, Spain, his PhD in cell biology and immunology from the University of California at Irvine, and a Diplomate from the European College of Transplantation. He served as chief of Plastic and Reconstructive Surgery at the MD Anderson Cancer Center in Madrid, Spain. Dr. Llull has received numerous awards and co-holds with Dr. Adam Katz several US and international patents related to tissue engineering, device biotechnology, and stem cells. He is a founder and past Chairman of the International Federation of Adipose Technologies and Science (IFATS), is a founder of StemSource, Inc., and enabled the first cell vaccine for brain tumors in Europe as a consultant of NorthWest BioTherapeutics. Dr. Llull is currently Director of STEM Center Mallorca, providing advanced regenerative therapies based on adipose biotechnology.



Dr. Patrick is a world-renowned plastic surgeon known for his achievements in breast and aesthetic surgeries. A graduate of Vanderbilt University School of Medicine, he is a pioneer of microsurgery and the field of breast reconstruction. Dr. Maxwell invented the textured tissue expander (used worldwide for breast reconstruction for the last 20 years), worked with Allergan to create a series of breast implants, and developed “flap” procedures. He founded Baptist Hospital Institute for Aesthetic and Reconstructive Surgery in Nashville, Tennessee, has written over 100 scientific articles, and has lectured and performed live surgical demonstrations in over 20 countries. He holds 10 US patents (with seven more pending) for medical devices and has received numerous professional awards—most recently including the U.S. Congressional Recognition of Merit, Clinician of the Year Award by the American Association of Plastic Surgeons, and the Presidential Award from the American Society of Plastic Surgeons.


Clinical and Training Specialist

Claire has been a scientist for 20 years including working as a forensic DNA analyst for Cellmark Forensics in the UK and US. For GID BIO she works as a clinical and training specialist, designing and implementing training courses, with a particular emphasis on e-learning, as well as hands-on training in the operating theatre. She also carries out research and development and IT projects. She has worked in field applications and training development for several molecular biology companies including Qiagen, Oxford Immunotec and Cepheid (Danaher) in the EU and EMEA. She also works on projects to expand Coronavirus (SARS-CoV-2) testing capacities, including the development of a 20-minute SARS-CoV-2 test. Claire earned an undergraduate degree in forensic science and law; a postgraduate certificate in research methods, and a Ph.D. in molecular biology.


Board of Directors

John Marous has led the development of new-start innovative technology businesses since 2002 as CEO of CarrierWeb, LLC (Atlanta, GA, 2003-2011) and CEO and Chairman of CardiacAsisst, Inc. (Pittsburgh, PA 2011-2018). As both businesses have exited to strategic entities, Mr. Marous is now involved in several new technology companies, serving as Chairman of HeartIO, Inc.(Pittsburgh, PA – artificial intelligence in diagnosis of heart disease), Chairman of IACtEx, LLC (Buffalo, NY – manufacturing management systems via internet of things connectivity), director of Inc. (Pittsburgh, PA – artificial intelligence to detect stroke in situ during surgery), strategic advisor to Optimus Technologies, Inc. (Pittsburgh, PA – zero emission large trucks/vehicles), and strategic advisor to Heart Repair Technologies, Inc (San Jose, CA – percutaneous mitral valve repair). In the medical device field, he has served as head of R&D, head of Regulatory Affairs, head of Clinical Affairs, in addition to being the complete strategic sales responsibility, with the intent of managing promotion risks related to labeling. He has degrees of BS (in EE) from Cornell University in 1981 and MS from Carnegie Mellon University in 1985.


Board of Directors, Founder

J. William received his MD from Duke University, followed by General Surgery Residence at Case-Western Reserve University and Plastic Surgery Residency at Johns Hopkins University. He was a Clinical/Research Oncology Fellow in the Surgery Branch at the National Institutes of Health and is Board Certified in General Surgery and in Plastic and Reconstructive Surgery. He was Professor and Chief of Plastic Surgery at the University of Pittsburgh Medical Center for 21 years, is Past President of the American Association of Plastic Surgeons and multiple other medical organizations and is author or co-author of more than 200 peer-reviewed scientific publications. As an entrepreneur, he is co-inventor of multiple patents and co-founder of numerous businesses including CellSource, Inc.; StemSource, Inc.; Human Analytix, Inc.; Illumineer, Inc.; and Life Science Enhancement Corporation. He is currently Chairman and co-founder of The GID Group, Inc.


Board of Directors

Nicholas Pachuda is a highly experienced life science executive committed to bringing transformational innovation to the clinic. He possesses deep clinical, technical, and business expertise with both multinationals and startups. He has operational leadership experience as a general manager with commercial P&L responsibility, as well as business development/external innovation and R&D and investment experience as a VC Venture Partner and PE Strategic Advisor. He has served as a startup board member and board advisor.

Dr. Pachuda’s professional experience includes: Peptilogics, Inc, Senior Vice President, Portfolio & Development; Johnson & Johnson, Vice President, External Innovation and Enabling Technologies, DePuy Synthes, Synthes Trauma (a Johnson & Johnson Company), Vice President Marketing and Business Development; Scient’x Spine—with HealthPoint Capital, Vice President Marketing, Professional Education, Clinical Affairs and Compliance; Small Bone Innovations, VP Business Development, Medical Education and Clinical Studies; Arthrex, Product Manager.  He holds a BS in Biology, Chemistry, History and Philosophy of Science from the University of Pittsburgh and a D.P.M. in podiatry from the Pennsylvania College of Podiatric Medicine.


Director of Regulatory Affairs

Stephen is a medical device Quality Assurance and Regulatory executive with over 29 years in the medical device industry.  His experience includes developing and implementing quality systems in all elements of 21 CFR 820 (Medical Device Quality System Regulation), ISO 13485 (CE Medical Device) and 21 CFR 1270/1271 (Human Cellular and Tissue Products). At GID BIO Stephen Stephen will direct regulatory affairs and quality assurance, helping to ensure that all products are high quality and comply with government regulations.


Director of Clinical Affairs

Dr. Sandeep Samudre grew up in Virginia Beach and received his Ph.D. in Ocular Pharmacology and Integrative Physiology, and his MPH in Healthcare Management and Biostatistics from Eastern Virginia Medical School, Norfolk, VA.

Sandeep has an extensive skill set, which spans over two decades, in developing medical devices, investigational new drugs and all aspects of conducting clinical trials including PMA, 510K and IND. Sandeep has consulted with several pharmaceutical companies and CRO’s in developing clinical trials, statistical support and publications. Sandeep has also served as a Director of Clinical Operations and Executive Director for several startup companies. Sandeep thrives in the startup realm and is excited to be part of the GID Bio team as the Director of Clinical Affairs.

Skip to content